Prodrug Information
| Prodrug General Information | Top | |||||
|---|---|---|---|---|---|---|
| Prodrug ID |
DP93IF
|
|||||
| Prodrug Name |
NAP-G2-Asp
|
|||||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |||
| Activation |
Prodrug 
|
|
Parent Drug 
|
|||
| 2D MOL | 2D MOL 3D MOL | |||||
| Prodrug Strategy |
Classical prodrug strategy
[Carrier linked prodrug]
|
|||||
| Improved property |
Increase solubility
|
[1] | ||||
| Description |
NAP-G2-Asp shows 90-fold increased solubility in water at pH7 (prodrug: 17.22mg/ml, parent drug: 0.19mg/ml).
|
[1] | ||||
| Parent Drug General Information | Top | |||||
|---|---|---|---|---|---|---|
| Parent Drug ID |
DMD6I9
|
|||||
| Parent Drug Name |
Naproxen
|
|||||
| Synonyms |
(S)-Naproxen; (+)-Naproxen; Naprosyn; Equiproxen; Naproxene; Aleve; (S)-(+)-Naproxen; (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Laraflex; (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; d-Naproxen; Naproxenum; Calosen; Naprosyne; Naproxeno; Nycopren; Bonyl; Naixan; Reuxen; Axer; (+)-(S)-Naproxen; Ec-Naprosyn; naproxen(+); (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; Acusprain; Anexopen; Arthrisil; Artrixen; Artroxen; Bipronyl; Clinosyn; Danaprox; Flexipen; Leniartil; Novonaprox; Anaprox; Apronax; Artagen; Atiflan; Congex; Daprox; Genoxen; Lefaine; Nafasol; Nalyxan; Napflam; Napmel; Naposin; Napren; Naprius; Veradol; Fuxen; Naxen; Naxyn; Xenar; Dysmenalgit N; Apo-Naproxen; Floginax; Headlon; Napratec; Naprontag; Narocin; Naxopren; Prafena; Priaxen; Pronaxen; Rheumaflex; Saritilron; Sinartrin; Soproxen; Sutolin; Tohexen; Traumox; Flexen; Napxen; Noflam; Patxen; Rahsen; Sinton; Sutony; Velsay; Vinsen; Narma; Roxen; Anax; (S)-2-(6-Methoxy-2-naphthyl)propionic acid; Flanax Forte; Naprosyn LLE; Napren E; Proxen LE; Naxen F; Proxen LLE; U-Ritis; (+)-2-(Methoxy-2-naphthyl)-propionic acid; RS-3540; Naprosyn LLE Forte; Naproxi 250; Naproxi 500; (S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid; Naxyn 250; Naxyn 500; (S)-2-(6-Methoxy-2-naphthyl)propanoic acid; Equiproxen (Veterinary); Apo-Napro-NA; Naproxene [INN-French]; Naproxenum [INN-Latin]; Naproxeno [INN-Spanish]; d-2-(6-Methoxy-2-naphthyl)propionic acid; (+)-2-(Methoxy-2-naphthyl)-propionsaeure; Dysmenalgit; Diocodal; Prexan; CG 3117; CCRIS 5265; HSDB 3369; (2S)-2-(6-methoxy-2-naphthyl)propanoic acid; EINECS 244-838-7; MFCD00010500; CHEMBL154; RS 3540; (+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid; Methoxypropiocin; CAS-22204-53-1; Naprosin; 26159-31-9; Xenar-CR; 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-; Naprolag; Naprosine; Naprosy; Panoxen; Proxine; Mnpa; SR-01000075977; DL Naproxen; Naproxen [USAN:BAN:INN:JAN]; Naprosyn (TN); Naproxen,(S); NPS; Naproxen [USAN:USP:INN:BAN:JAN]; (S)-(+)-Naproxene; (+)NAPROXEN; Epitope ID:139974; UPCMLD-DP001; 2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen); SCHEMBL3046
Click to Show/Hide
|
|||||
| Formula |
C14H14O3
|
|||||
| Canonical SMILES |
C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O
|
|||||
| InChI |
1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
|
|||||
| InChIKey |
CMWTZPSULFXXJA-VIFPVBQESA-N
|
|||||
| CAS Number |
CAS 22204-53-1
|
|||||
| PubChem Compound ID | ||||||
| ChEBI ID |
CHEBI:7476
|
|||||
| References | Top | |||||
|---|---|---|---|---|---|---|
| REF 1 | Synthesis and preliminary evaluation in vitro of novel naproxen-dendritic peptide conjugates. Drug Deliv. 2009 Aug;16(6):348-56 | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.